Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.70
+0.01000.01%
Volume:125.50K
Turnover:12.14M
Market Cap:24.29B
PE:-12.44
High:97.32
Open:97.24
Low:96.22
Close:96.69
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.35
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.19
PE(LYR):-17.52

Loading ...

BioNTech price target raised to $140 from $132 at Berenberg

TIPRANKS
·
Yesterday

Berenberg Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
Yesterday

Jefferies Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)

TIPRANKS
·
Sep 15

BioNTech and OncoC4 Report Survival Gains for Gotistobart in Phase 3 Squamous NSCLC Trial

TIPRANKS
·
Sep 14

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Sep 14

BioNTech Says Lung Cancer Drug Candidate Prolonged Lives in Trial

Reuters
·
Sep 14

Movement Alert|BioNTech SE Rises 5.04% in Pre-Market Trading, Phase 3 Lung Cancer Trial Shows Statistically Significant Survival Benefit

Market Focus
·
Sep 14

BioNTech's Lung Cancer Drug Nearly Doubles Survival in Late-Stage Trial, Boosting Oncology Pivot

Stock News
·
Sep 14

BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003

TIPRANKS
·
Sep 14

BioNTech, OncoC4 Report Positive Overall Survival Data From Phase 3 Trial of Gotistobart in Lung Cancer

MT Newswires Live
·
Sep 14

BioNTech CEO Uğur Şahin Sells 20,500 Shares for $1.97 Million

Reuters
·
Sep 12

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

Berenberg Bank Sticks to Their Hold Rating for Bilfinger (0NRG)

TIPRANKS
·
Sep 10

Opus Genetics price target raised to $16 from $13 at Chardan

TIPRANKS
·
Sep 10

BioNTech SE ADR Slides 4.9%, Underperforms Market

Dow Jones
·
Sep 09

BioNTech CEO Ugur Sahin Sells Ordinary Shares Worth $7.86 Million

Reuters
·
Sep 09

Movement Alert|BioNTech SE Falls 5.08% in Regular Trading, BMO Capital Downgrades Rating to Market Perform

Market Focus
·
Sep 08

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Sep 08